Literature DB >> 31786725

Investigation of Molecular Properties that Influence the Permeability and Oral Bioavailability of Major β-Boswellic Acids.

Tarun Sharma1, Snehasis Jana2.   

Abstract

BACKGROUND AND OBJECTIVES: Boswellic acids (BAs) include β-boswellic acid (BA), 3-acetyl-β-boswellic acid, 11-keto-β-boswellic acid, 3-acetyl-11-keto-β-boswellic acid, β-boswellic alcohol, and 3-acetyl-11-hydroxy-β-BA from Boswellia species, and are the main active ingredients of Boswellia serrata extracts (BSE). BSE have been used for the treatment of different inflammatory diseases; however, their pharmaceutical development has been severely limited by their poor oral bioavailability. The aims of this study were to investigate the molecular properties of six BAs, and to determine their experimental aqueous solubility, partition coefficient (Log P), gastrointestinal stability, adsorption-desorption kinetics, and permeability studies.
METHODS: The physicochemical properties of six BAs were obtained from SMILES representations using ChemDraw, and MarvinSketch. The molecular properties were also determined experimentally. The permeability studies were performed using parallel artificial membrane permeability assay (PAMPA), and Caco-2 cells.
RESULTS: The experimental Log P values of BAs correlated well (R2 = 0.94) with the calculated Log P values. Metabolic stability data confirmed that BAs were found to be unstable in simulated gastrointestinal fluids and intestinal S9 fractions. The apparent permeability (Papp) range of BAs in both PAMPA and Caco-2 for the apical (AP) to basolateral (BL) was in the range of 0.52 ± 0.05 × 10-6 to 2.84 ± 0.14 × 10-6cm/s. The efflux ratio of Papp (BL → AP) to Papp (AP → BL) for all BAs was < 2 in Caco-2 cells, suggesting greater permeability in the absorptive direction. Caco-2 cell adsorption studies confirmed the accumulation of BAs (35-55%) inside the enterocytes. These compounds exhibited a strong correlation between PAMPA and Caco-2 cell monolayer permeation data.
CONCLUSIONS: The results of the present study have shown an empirical relationship between the molecular properties and intestinal absorption of BAs for the first time.

Entities:  

Year:  2020        PMID: 31786725     DOI: 10.1007/s13318-019-00599-z

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

1.  SZB120 Exhibits Immunomodulatory Effects by Targeting eIF2α to Suppress Th17 Cell Differentiation.

Authors:  Linjiao Chen; Jing Bai; Danhong Peng; Yuanyuan Gao; Xiaojie Cai; Junxun Zhang; Sibei Tang; Liman Niu; Yang Sun; Fangzhou Lou; Hong Zhou; Qianqian Yin; Zhikai Wang; Libo Sun; Xuemei Du; Zhenyao Xu; Hong Wang; Qun Li; Honglin Wang
Journal:  J Immunol       Date:  2021-01-22       Impact factor: 5.422

Review 2.  Potential therapeutic effects of boswellic acids/Boswellia serrata extract in the prevention and therapy of type 2 diabetes and Alzheimer's disease.

Authors:  Adel A Gomaa; Hanan A Farghaly; Yasmin A Abdel-Wadood; Ghada A Gomaa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-09-20       Impact factor: 3.195

3.  Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study.

Authors:  Mustafa M Kadhim; Abbas Washeel Salman; Ameerah Mrebee Zarzoor; Wesam R Kadhum
Journal:  J Mol Liq       Date:  2021-05-08       Impact factor: 6.165

4.  Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease.

Authors:  Mario-Livio Jeličić; Daniela Amidžić Klarić; Jelena Kovačić; Donatella Verbanac; Ana Mornar
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-04

Review 5.  Considerations to Be Taken When Carrying Out Medicinal Plant Research-What We Learn from an Insight into the IC50 Values, Bioavailability and Clinical Efficacy of Exemplary Anti-Inflammatory Herbal Components.

Authors:  Mona Abdel-Tawab
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

Review 6.  Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.

Authors:  Adel A Gomaa; Hamdy S Mohamed; Rasha Bakheet Abd-Ellatief; Mohamed A Gomaa
Journal:  Inflammopharmacology       Date:  2021-07-05       Impact factor: 4.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.